Brentuximab vedotin plus doxorubicin, vinblastine, and dacarbazine in patients with advanced-stage, classical Hodgkin lymphoma: a prespecified subgroup analysis of high-risk patients from the ECHELON-1 study

dc.contributor.authorHutchings, Martin
dc.contributor.authorRadford, John
dc.contributor.authorAnsell, Stephen M.
dc.contributor.authorIllés, Árpád
dc.contributor.authorSureda, Anna
dc.contributor.authorConnors, Joseph M.
dc.contributor.authorSýkorová, Alice
dc.contributor.authorShibayama, Hirohiko
dc.contributor.authorAbramson, Jeremy S.
dc.contributor.authorChua, Neil S.
dc.contributor.authorFriedberg, Jonathan W.
dc.contributor.authorKořen, Jan
dc.contributor.authorLaCasce, Ann Steward
dc.contributor.authorMolina, Lysiane
dc.contributor.authorEngley, Gerald
dc.contributor.authorFenton, Keenan
dc.contributor.authorJolin, Hina A.
dc.contributor.authorLiu, Rachael
dc.contributor.authorGautam, Ashish
dc.contributor.authorGallamini, Andrea
dc.date.accessioned2021-04-19T08:04:31Z
dc.date.available2021-04-19T08:04:31Z
dc.date.issued2021
dc.date.oa2021-04-19
dc.date.pasync2022-03-23T01:30:22Z
dc.date.updated2022-03-23T01:30:22Z
dc.description.correctorLB
dc.identifier.citationHematological Oncology. -39 : 2 (2021), p. 185-195. -Hematol. Oncol. - 0278-0232
dc.identifier.doihttp://dx.doi.org/10.1002/hon.2838
dc.identifier.issn0278-0232
dc.identifier.opachttp://webpac.lib.unideb.hu:8082/ebib/CorvinaWeb?action=cclfind&resultview=long&ccltext=idno+BIBFORM093521
dc.identifier.urihttp://hdl.handle.net/2437/306129
dc.identifier.urlhttps://onlinelibrary.wiley.com/doi/10.1002/hon.2838
dc.languageeng
dc.rights.accessopen access article
dc.subject.mabOrvostudományok
dc.subject.mabKlinikai orvostudományok
dc.titleBrentuximab vedotin plus doxorubicin, vinblastine, and dacarbazine in patients with advanced-stage, classical Hodgkin lymphoma: a prespecified subgroup analysis of high-risk patients from the ECHELON-1 study
dc.typeidegen nyelvű folyóiratközlemény külföldi lapban
Fájlok
Eredeti köteg (ORIGINAL bundle)
Megjelenítve 1 - 1 (Összesen 1)
N/A
Név:
FILE_UP_1_Brentuximab vedotin plus doxorubicin.pdf
Méret:
4.63 MB
Formátum:
Adobe Portable Document Format
Leírás:
kiadói változat